Ilika plc stock analysis
Want to see GB:IKA full AI Analyst Report?
Ilika plc (IKA) Share Price & Analysis
IKA Stock Chart & Stats
- Day’s Range
- GBX 19.00 - GBX 20.00
- 52-Week Range
- GBX 18.00 - GBX 47.00
- Previous Close
- GBX 19.50
- Volume
- N/A
- Average Volume (3M)
- 170.42K
- Market Cap
- GBP 38.78M
- Enterprise Value
- GBP 55.40M
- Total Cash (Recent Filing)
- GBP 5.35M
- Total Debt (Recent Filing)
- GBP 1.08M
- Price to Earnings (P/E)
- ―
- Beta
- 0.58
- Next Earnings
- Jan 28, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Protected Technology And Differentiated Performance
The 88-patent portfolio and reported performance benefits provide a defensible technology base for licensing and commercialization. Faster charging, lower vehicle weight and improved safety could strengthen customer adoption if validation continues across automotive and industrial applications.
Commercialization Progress Across Two Product Lines
Progress from development toward customer deliveries and product MVPs demonstrates that Ilika is converting laboratory technology into commercial offerings. Activity across miniature Stereax batteries and larger Goliath cells broadens potential revenue pathways over the medium term.
Low Financial Leverage Supports Strategic Flexibility
Very low leverage reduces fixed financial obligations and near-term balance-sheet pressure compared with highly indebted peers. This gives Ilika greater flexibility to pursue partnerships, grants and product validation without the added burden of substantial interest-bearing debt.
Bears Say
Persistent Losses And Negative Margins
Persistent negative gross profit and operating losses show that current commercial activity has not yet produced a scalable, profitable business model. Until pricing, production economics or revenue scale improve, growth may continue to require external funding rather than internally generated earnings.
Continued Cash Burn And Funding Dependence
Ongoing operating and free-cash-flow deficits mean Ilika cannot currently fund its development and commercialization program from operations. Dependence on grants, partnerships and capital raises creates execution and dilution risk if funding is delayed or insufficient for scale-up.
Limited Scale And Delayed Large-market Revenue
Current pilot capacity is suited to prototypes and smaller applications but remains far below automotive gigascale requirements. Lengthy validation and option-to-license processes could defer material revenue, leaving the company exposed to extended commercialization timelines and resource constraints.
IKA FAQ
What was Ilika plc’s price range in the past 12 months?
What is Ilika plc’s market cap?
When is Ilika plc’s upcoming earnings report date?
How were Ilika plc’s earnings last quarter?
Is Ilika plc overvalued?
Does Ilika plc pay dividends?
What is Ilika plc’s EPS estimate?
How many shares outstanding does Ilika plc have?
What happened to Ilika plc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Ilika plc?
What is the TipRanks Smart Score and how is it calculated?
Ilika plc Stock Smart Score
Company Description
Ilika plc
Ilika plc, an enterprise established in 2004 with its headquarters in Romsey, United Kingdom, focuses on the conception, refinement, and commercial production of solid-state battery technology. These advanced power cells are distributed globally under their Stereax brand, primarily serving markets in the UK, Asia, mainland Europe, and North America. The company's battery solutions find application across numerous sectors, such as industrial Internet of Things, medical apparatus, various transportation systems including electric vehicles, and portable consumer electronics, as well as supporting smart city initiatives.
- Sector
- Industrials
- Industry
- Electrical Equipment & Parts
- CEO
- Graeme Purdy
- Employees
- 68
- Website
- www.ilika.com
- Address
- The Quadrangle, Romsey, HM, SO51 9DL, GB
Ilika plc (IKA) Earnings & Revenues
IKA Earnings Call
Earnings Call SentimentNeutral
The call presented meaningful technical and commercial progress: first Stereax revenues, manufacturing partnerships (Cirtec), automated pilot line, positive prototype feedback from OEMs, defense and Brompton collaborations, and continued grant support. However, financials remain an important constraint — revenue is still modest, EBITDA losses widened (~19% year‑on‑year), loss per share increased (~14.9%), and pilot capacity and resource limitations constrain immediate scale‑up. There is clear momentum on the technology and validation front but material execution, funding and timing risks remain.
View all GB:IKA earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 5 | 13 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 1 | 0 | 11 |








